Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers.
Study Design
- Study Type
- cross-sectional observational study
- Sample Size
- 260
- Intervention
- Restless leg syndrome in chronic hemodialysis patients in Mashhad hemodialysis centers. None
- Comparator
- Placebo
- Effect Direction
- Neutral
- Risk of Bias
- High
Abstract
Introduction: Restless leg syndrome (RLS) is a sensory motor disorder. Patients with this syndrome have serious and uncontrollable desire to move their legs, which is mostly due to an uncomfortable feeling intensified when they are motionless. It may be a genetic disorder or secondary to iron deficiency, neurodegenerations, pregnancy, some drugs and severe kidney diseases. Objectives: This study was designed to find out the prevalence and its risk factors of RLS in hemodialysis patients. Patients and Methods: This multicenter cross-sectional study was done on 260 hemodialysis patients. The prevalence of RLS was measured using International Restless Legs Syndrome Study Group (IRLSSG)'s RLS Questionnaire (RLSQ). Potential risk factors for RLS including underlying cause of chronic renal failure, duration on dialysis, biochemical tests, dialysis adequacy, and erythropoietin and also venofer dosage in recent month and demographic data were also evaluated. Results: The prevalence of RLS was 55% including 59.4% males and 40.6% females. Their mean age of RLS patients and their dialysis duration were significantly higher than other group (P<0.05). Their body mass index (BMI) and serum calcium were significantly higher (P<0.05). However erythropoietin dosage and serum hemoglobin level were lower in RLS patients (P<0.05). Significant predictors of RLS were history of diabetes mellitus (DM), hypertension (HTN), smoking (P<0.05). There was not significant relation between RLS and dialysis adequacy, serum intact parathyroid hormone (iPTH), urea, ferritin and venofer dosage (P>0.05). Conclusion: According to the results, RLS is a common disorder in hemodialysis patients which can affect strongly on their life. So particular attention and sooner diagnosis of RLS in high risk patients for better management is necessary.
Full Text
Tables
Table 1
|
|
|
|
|
| M/F | 85/58 | 72/45 | 0.731 |
| Age (y) | 51.72±14.49 | 45.65±16.57 | 0.002 |
| Weight (kg) | 62.94±13.02 | 59.91±12.32 | 0.057 |
| Height (cm) | 162.42±16.47 | 163.90±9.25 | 0.386 |
| BMI(kg/m2) | 23.48±4.34 | 22.22±3.99 | 0.017 |
| Dialysis duration (y) | 4.72±5.03 | 3.10±4.53 | 0.008 |
| PTH (ng/L) | 485.28±451.85 | 476.22±425.96 | 0.869 |
| Ferrittin (ng/mL) | 1107±07 | 490.80±428.83 | 0.093 |
| Hemoglobin (g/ dL) | 11.04±1.98 | 11.70±2.74 | 0.031 |
| Urea (mg/dL) | 126.78±34.95 | 128.72±37.03 | 0.665 |
| Calcium(mg/dL) | 8.43±0.86 | 8.20±0.82 | 0.034 |
| Phosphosrus (mg/dL) | 5.79±1.37 | 5.54±1.68 | 0.187 |
| Kt/V | 1.36±0.33 | 1.43±0.36 | 0.113 |
| EPO dosage (unit/wk) | 7804.19±6610.12 | 10111.11±6543.98 | 0.005 |
| Venofer dosage (mg/mon) | 531.5±0.50 | 555.6±0.49 | 0.699 |
Table 2
|
|
| |
| HTN | 46 (59.1%) | 31 (40.3%) |
| DM | 26 (81.2%) | 6 (18.8%) |
| Diabetes + HTN | 27 (67.5%) | 13 (32.5%) |
| Urologic diseases | 17 (36.2%) | 30 (63.8%) |
| Trauma | 2 (33.3%) | 4 (66.7%) |
| Other diseases | 23 (41.1%) | 33 (58.9%) |
Table 3
|
|
|
|
|
| Anti-histaminic drug | 32(22.4%) | 22(18.8%) | 0.48 |
| SSRI | 16(11.2%) | 11(9.4%) | 0.638 |
| Benzodiazepines | 22 (15.4%) | 11(9.4%) | 0.149 |
| Anticonvulsant | 9 (6.3%) | 8(6.8%) | 0.86 |
| TCA | 13(9.1%) | 5(4.3%) | 0.128 |
| Gabapentin | 30(21%) | 10(8.5%) | 0.006 |
References
- Periodic limb movements in sleep — endophenotype for restless legs syndrome? N Engl J Med, 2007
- Prevalence and sleep related disorders of restless leg syndrome in hemodialysis patients Nephrourol Mon, 2015
- Subjective and objective sleep quality in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study Am J Kidney Dis, 2008
- Restless legs syndrome in end-stage renal disease Sleep Med, 2004
- Restless leg syndrome: a neglected diagnosis Nephro Urol Mon, 2014
- Epidemiology, impact, and treatment options of restless legs syndrome in end-stage renal disease patients: an evidence-based review Kidney Int, 2014
- Untitled
- Restless leg syndrme N Engl J Med, 2003
- Determination of the prevalence and associated factors of restless legs syndrome (RLS) in Iranian non-traumatic patients who referred to neurology and orthopedic clinics Iran J Neurol, 2008
- Prevalence of restless legs syndrome in North American and Western European populations: a systematic review Sleep Med, 2011
- Restless Legs Syndrome in Patients on Dialysis Saudi J Kidney Dis Transpl, 2009
- Restless legs syndrome: a review of clinical and pathophysiologic features J Clin Neurophysiol, 2001
- Prevalence of sleep disturbances in Chinese patients with end stage renal failure on maintenance hemodialysis Med Sci Monit, 2002
- Restless legs syndrome in patients on dialysis Am J Kidney Dis, 2004
- Restless legs syndrome in hemodialysis patients in India: a casecontrolled study Sleep Med, 2003
- Restless legs syndrome in end-stagerenal disease: clinical characteristics and associated comorbidities Sleep Med, 2010
- Restless legs syndrome, insomnia and quality of life inpatients on maintenance dialysis Nephrol Dial Transplant, 2005
- Sleep disorders inpatients with end-stage renal disease undergoingdialysis therapy Nephrol Dial Transplant, 2006
- Diagnosis and management of sleep apnea syndrome and restless legs syndrome in dialysis patients Semin Dial, 2006
- Restless legs syndrome in patients on hemodialysis Saudi J Kidney Dis Transpl, 2011
- Prevalence of sleep disturbances in chinese patients with end-stage renal failure on continuous ambulatory peritoneal dialysis Am J Kidney Dis, 2000
- Restless legs syndrome in hemodialysis patients: health-related quality of life and laboratory dataanalysis Clin Nephrol, 2006
- Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis Am J Kidney Dis, 2003
- Restless legs syndrome Am Fam Physician, 2008
- A doubleblind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome Am J Kidney Dis, 2004
- The role of iron in restless legs syndrome Mov Disord, 2007
- Restless legs syndrome and hypertension in middle-aged women Hypertension, 2011
- Sleep behavior disorders in a large cohort of Chinese (Taiwanese) patients maintained by long term hemodialysis Am J Kidney Dis, 2006
Used In Evidence Reviews
Similar Papers
Journal of the American Academy of Dermatology · 2006
The diagnosis and treatment of iron deficiency and its potential relationship to hair loss.
The Journal of investigative dermatology · 2003
Decreased serum ferritin is associated with alopecia in women.
Pediatrics · 2012
The diet factor in attention-deficit/hyperactivity disorder.
Journal of clinical and diagnostic research : JCDR · 2015
Telogen Effluvium: A Review.
Journal of the American Academy of Dermatology · 2019
Comorbidities in alopecia areata: A systematic review and meta-analysis.
Sleep medicine clinics · 2015